Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Ring

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 25, 1999
Flavin-containing monooxygenase-mediated N-oxidation of the M(1)-muscarinic agonist xanomelineB J Ring, S A Wrighton, S L Aldridge, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2001
Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetineB J Ring, J A Eckstein, J S Gillespie, et al.
Pharmacogenetics|April 26, 2000
Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitorsS Ekins, G Bravi, S Binkley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitorsS Ekins, G Bravi, S Binkley, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitorsS Ekins, G Bravi, S Binkley, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
Further characterization of the expression in liver and catalytic activity of CYP2B6S Ekins, M Vandenbranden, B J Ring, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1987
Chronic effects of fractionated renal irradiation on the pharmacokinetics of intravenous methotrexateJ S Holcenberg, J E Moulder, B A Karmen, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6S Ekins, G Bravi, B J Ring, et al.
Cancer Research|November 1, 1984
Effects of single-dose and fractionated cranial irradiation on rat brain accumulation of methotrexateB A Kamen, J E Moulder, L E Kun, et al.
Pharmaceutical Research|April 17, 2001
A population approach to enzyme characterization and identification: application to phenacetin O-deethylationD J Belle, B J Ring, S R Allerheiligen, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 25, 1999
Flavin-containing monooxygenase-mediated N-oxidation of the M(1)-muscarinic agonist xanomelineB J Ring, S A Wrighton, S L Aldridge, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2001
Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetineB J Ring, J A Eckstein, J S Gillespie, et al.
Pharmacogenetics|April 26, 2000
Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitorsS Ekins, G Bravi, S Binkley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitorsS Ekins, G Bravi, S Binkley, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitorsS Ekins, G Bravi, S Binkley, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
Further characterization of the expression in liver and catalytic activity of CYP2B6S Ekins, M Vandenbranden, B J Ring, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1987
Chronic effects of fractionated renal irradiation on the pharmacokinetics of intravenous methotrexateJ S Holcenberg, J E Moulder, B A Karmen, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6S Ekins, G Bravi, B J Ring, et al.
Cancer Research|November 1, 1984
Effects of single-dose and fractionated cranial irradiation on rat brain accumulation of methotrexateB A Kamen, J E Moulder, L E Kun, et al.
Pharmaceutical Research|April 17, 2001
A population approach to enzyme characterization and identification: application to phenacetin O-deethylationD J Belle, B J Ring, S R Allerheiligen, et al.
Pageof 4